"Shouldn't Overreact To Delays In Covaxin Approval": Biocon's Kiran Shaw To NDTV
"This (approval of Covaxin) is excellent news. WHO follows stringent guidelines - a lot of data points need to be submitted. We should not overreact to the delay in its approval," says Biocon's Executive Chairperson Kiran Mazumdar Shaw.
![Gadgets 360 With Technical Guruji: Ask TG [June 1, 2024]](https://c.ndtvimg.com/2024-06/7jvriahc_ask-tg_640x480_01_June_24.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Ask TG [June 1, 2024]")
